Filter

Refine by collections

  • Metabolic Syndrome and Diabetes (4)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 4 of 4 items for :

  • "treatment initiation" x
  • Metabolic Syndrome and Diabetes x
Clear All
Vânia Benido Silva Department of Endocrinology, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Vânia Benido Silva in
Google Scholar
PubMed Close
,
Liliana Fonseca Department of Endocrinology, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Liliana Fonseca in
Google Scholar
PubMed Close
,
Maria Teresa Pereira Department of Endocrinology, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Maria Teresa Pereira in
Google Scholar
PubMed Close
,
Joana Vilaverde Department of Endocrinology, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Joana Vilaverde in
Google Scholar
PubMed Close
,
Clara Pinto Department of Obstetrics, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Clara Pinto in
Google Scholar
PubMed Close
,
Fernando Pichel Department of Nutrition, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Fernando Pichel in
Google Scholar
PubMed Close
,
Maria do Céu Almeida In representation of the Diabetes and Pregnancy Study Group of the Portuguese Society of Diabetology, Lisbon, Portugal

Search for other papers by Maria do Céu Almeida in
Google Scholar
PubMed Close
, and
Jorge Dores Department of Endocrinology, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Jorge Dores in
Google Scholar
PubMed Close

control. Higher pregestational BMI and fasting PG levels in OGTT, earlier GDM diagnosis and metformin treatment initiation, and hypertension increased the risk of metformin monotherapy failure, although only the BMI value, fasting PG levels in OGTT and

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-21-0540
Volume/Issue:
Volume 11: Issue 5
Open access
Marie Oertel Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Marie Oertel in
Google Scholar
PubMed Close
,
Christian G Ziegler Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany
Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany

Search for other papers by Christian G Ziegler in
Google Scholar
PubMed Close
,
Michael Kohlhaas Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Michael Kohlhaas in
Google Scholar
PubMed Close
,
Alexander Nickel Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Alexander Nickel in
Google Scholar
PubMed Close
,
Simon Kloock Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Simon Kloock in
Google Scholar
PubMed Close
,
Christoph Maack Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Christoph Maack in
Google Scholar
PubMed Close
,
Vasco Sequeira Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Vasco Sequeira in
Google Scholar
PubMed Close
,
Martin Fassnacht Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Martin Fassnacht in
Google Scholar
PubMed Close
, and
Ulrich Dischinger Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital, University of Würzburg, Würzburg, Germany
Comprehensive Heart Failure Center, Würzburg, Germany

Search for other papers by Ulrich Dischinger in
Google Scholar
PubMed Close

intervals within the delivery time of the osmotic minipumps (42 days) for all treatment groups. At the time of treatment initiation, all treatment groups (starting at different time points) had comparable body weights (567 ± 48 g for group 1, 576 ± 6 g for

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0398
Volume/Issue:
Volume 13: Issue 3
Open access
Pernille H Hellmann Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Pernille H Hellmann in
Google Scholar
PubMed Close
,
Jonatan I Bagger Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed Close
,
Katrine R Carlander Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Katrine R Carlander in
Google Scholar
PubMed Close
,
Katrine B Hansen Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Katrine B Hansen in
Google Scholar
PubMed Close
,
Julie L Forman Section of Biostatistics, Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Julie L Forman in
Google Scholar
PubMed Close
,
Joachim Størling Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Joachim Størling in
Google Scholar
PubMed Close
,
Elizaveta Chabanova Department of Radiology, Herlev Hospital, University of Copenhagen, Herlev, Denmark

Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed Close
,
Jens Holst Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jens Holst in
Google Scholar
PubMed Close
,
Tina Vilsbøll Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed Close
, and
Filip K Knop Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Filip K Knop in
Google Scholar
PubMed Close

Parameters calculated from data recorded from 8:00 h at the day of prednisolone/prednisolone placebo treatment initiation until second magnetic resonance spectroscopy or the night before experimental day #2 whichever came first. b Welch two-sample t test. CV

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0334
Volume/Issue:
Volume 12: Issue 4
Open access
Merlin C Thomas Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia

Search for other papers by Merlin C Thomas in
Google Scholar
PubMed Close
,
Brendon L Neuen The George Institute for Global Health, Sydney, NSW, Australia

Search for other papers by Brendon L Neuen in
Google Scholar
PubMed Close
,
Stephen M Twigg The University of Sydney School of Medicine, Sydney, NSW, Australia
Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia

Search for other papers by Stephen M Twigg in
Google Scholar
PubMed Close
,
Mark E Cooper Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia

Search for other papers by Mark E Cooper in
Google Scholar
PubMed Close
, and
Sunil V Badve The George Institute for Global Health, Sydney, NSW, Australia
Department of Renal Medicine, St George Hospital, Sydney, NSW, Australia
Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Sunil V Badve in
Google Scholar
PubMed Close

prior to treatment initiation with SGLT2 inhibitors and to correct hypovolemia (particularly in elderly patients, in patients with impaired kidney function or low systolic blood pressure and in patients receiving diuretics) ( 69 , 70 , 71 , 72 ). In

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0005
Volume/Issue:
Volume 12: Issue 8
Open access